Funding and collaborators

Funding

  • South-Eastern Norway Regional Health Authority
  • The Research Council of Norway
  • Foundation DAM
  • SPARK Norway
  • UiO Growth House
  • National Center for Rare Disorders
  • Stiftelsen ALS Norge

Most important collaborators

National 

  • Stavanger University Hospital; 
Marie Bu Kvaløy
  • Haukeland universitetssjukehus, Bergen; Tom Eichele
  • NTNU og St. Olavs Universitetssykehus, Trondheim; 
Petter Moe Omland
  • Universitetssykehuset Nord-Norge; Sissel Løseth, 
Andreas Dybesland Rosenberger
  • Diakonhjemmet Hospital; 
Hilde Berner Hammer, Ulf Sundin
  • Research group of Orthopaedic Traumatology, OUH; 
Tore Fjalestad
  • Department of Research and Innovation, OUH; 
John-Anker Zwart
  • Neurogenetics Research Group, OUH; Kaja Kristine Selmer
  • The National Institute of Occupational Health in Norway; STAMI; Dagfinn Matre
  • Helse Førde HF; Kristoffer Noszka
  • Helse Fonna, Haugesund; 
Kirsten Solstrand
  • Sykehuset Vestfold, Tønsberg; Anders Horsdal
  • Sykehuset Innlandet; 
An-Magritt Dimmen
  • Sørlandet Sykehus, Kristiansand; Håvard Larsen
  • Helse Møre og Romsdal, Ålesund; Janne Marit Ertresvåg, 
Audun Olav Dahlberg
  • Helse Nord-Trøndelag; Anna Grav
  • Nordlandsykehuset, Bodø; 
Diana Hristova
  • Universitetet i Oslo; 
John-Anker Zwart
  • OsloMet; Anis Yazidi
  • Universitetet i Sør-Øst Norge; Mohsen Toorani
  • Nasjonalt senter for e-helseforskning; 
Gro-Hilde Severinsen
  • Høgskolen i Østfold, Universitetet i Agder og Norsk råd for digital etikk; 
Leonora Onarheim Bergsjø
  • Oslo Centre for Biostatistics & Epidemiology (OCBE); 
Andrew Reiner

  • Section for rare Neuromuscular disorders and EMAN, OUH; Kristin Ørstavik

  • Department of Neurology, OUH; Erik Taubøll

  • Department of Clinical & Biomedical Engineering, OUH; 
Christian Tronstad

  • Department of Physics, UiO; 
Ørjan Martinsen 

  • Norwegian School of Sport Sciences; May Grydeland

  • The VIKING consortium; 
Naimahmed Nesaragi, 
Sampsa Lohi, Uliana Brobakken,
Haukur Tyr Gudmundsson,
  • Denesha Kandiah Mahenthra

  • Inven2; Elin Melby

  • TSD; Ainar Drews

  • OsloMet; Per Koren Solvang

  • UiO Growth House; 
Nicolay Bérard-Andersen

International

  • University of Oxford, UK;
David Bennett
  • Aarhus University Hospital, Denmark;
Hatice Tankisi
  • David Geffen School of Medicine at UCLA - Los Angeles, USA; Joe Jabre
  • Leiden University Medical Center;
Martijn Tannemaat
  • Uppsala University Hospital, Sweden; 
Anna Punga
  • Harvard Medical School, USA; 
Seward Rutkove, Brandon Westover
  • University of Alberta, Canada; Kelvin Jones
  • Lund University; Erik Westhall
  • Monash University, Australia; Patrick Kwan
 
Scroll to top